A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
R-Pharm
R-Pharm
R-Pharm
Bristol-Myers Squibb
Amgen
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
Gilead Sciences
Rakuten Medical, Inc.
Merck Sharp & Dohme LLC
Hummingbird Bioscience
Akeso
GlaxoSmithKline
OncoResponse, Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Bristol-Myers Squibb
Seagen Inc.